{"id":918671,"date":"2025-12-11T08:23:46","date_gmt":"2025-12-11T13:23:46","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\/"},"modified":"2025-12-11T08:23:46","modified_gmt":"2025-12-11T13:23:46","slug":"aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\/","title":{"rendered":"Aurora Expands Leading Portfolio of High-Potency Medical Flower Products in Poland"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p class=\"prntac\">\n        <i>Latest Innovation\u00a0Brings New\u00a0Proprietary Cultivar\u00a0to Polish Patients\u00a0<\/i>\n      <\/p>\n<p class=\"prntar\">\n        <i>NASDAQ\u00a0| TSX: ACB<\/i>\n      <\/p>\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">EDMONTON, AB<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Dec. 11, 2025<\/span><\/span> \/PRNewswire\/ &#8211; Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces the launch of <b>Black Jelly<\/b>, a proprietary cultivar,\u00a0in <span class=\"xn-location\">Poland<\/span>, expanding\u00a0the\u00a0company&#8217;s\u00a0portfolio\u00a0of high-potency medical cannabis products in one of Europe&#8217;s fastest-growing markets. Grown and manufactured in Aurora&#8217;s Canadian GACP and EU-GMP certified\u00a0facilities, Black Jelly joins\u00a0<b>Farm Gas<\/b>\u00a0and\u00a0<b>Sourdough<\/b>\u00a0under the\u00a0<i>Cannabis\u00a0flos\u00a0Aurora <\/i>brand portfolio.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/2842794\/Aurora_Cannabis_Inc__Aurora_Expands_Leading_Portfolio_of_High_Po.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2842794\/Aurora_Cannabis_Inc__Aurora_Expands_Leading_Portfolio_of_High_Po.jpg\" title=\"Aurora Logo (CNW Group\/Aurora Cannabis Inc.)\" alt=\"Aurora Logo (CNW Group\/Aurora Cannabis Inc.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>&#8220;Aurora\u00a0is uniquely positioned to bring this novel\u00a0proprietary cultivar to\u00a0the\u00a0Polish market\u00a0thanks to the\u00a0company&#8217;s\u00a0advanced\u00a0genetic breeding program\u00a0and\u00a0unmatched\u00a0global cultivation excellence,&#8221;\u00a0said\u00a0Andreas Dotterweich, Senior VP of <span class=\"xn-person\">Aurora Europe<\/span>. &#8220;We\u00a0deeply\u00a0understand that prescribers want reliable, high-potency medical cannabis options for their patients, and we&#8217;re proud to offer\u00a0superior products\u00a0that consistently meet prescriber and patient needs.&#8221;\u00a0<\/p>\n<p>Black Jelly will be available\u00a0for Polish\u00a0prescribers from today, <span class=\"xn-chron\">December 11, 2025<\/span>, offering a cannabinoid profile of THC 27% \/ CBD &lt;1%.\u00a0A high-THC sativa derived from Alien Cake 3030 \u00d7 T037, Black Jelly features dense, large flowers with green and orange hues and a terpene profile characterized by sweet black liquorice and fruity undertones. The cultivar originates from Aurora&#8217;s\u00a0world leading\u00a0genetics program and is crafted using premium hang-drying and curing techniques.\u00a0<\/p>\n<p>Aurora continues to strengthen its leadership in international medical cannabis,\u00a0leveraging\u00a0its scientific\u00a0expertise, regulatory knowledge, and commitment to innovation to support patient access and market growth across Europe. With more than a decade of experience in global medical markets, Aurora\u00a0remains\u00a0the trusted partner in advancing <span class=\"xn-location\">Poland&#8217;s<\/span> medical cannabis ecosystem.<\/p>\n<p>\n        <b><br \/>\n          <u>About Aurora Cannabis\u00a0Inc.<\/u><br \/>\n        <\/b>\u00a0<\/p>\n<p>Aurora is opening the world to cannabis, serving both the medical and consumer markets\u00a0across Canada,\u00a0Europe,\u00a0Australia\u00a0and\u00a0New Zealand. Headquartered in\u00a0Edmonton, <span class=\"xn-location\">Alberta<\/span>, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company&#8217;s adult-use brand portfolio includes Drift, San Raf, Daily Special,\u00a0Tasty&#8217;s, Being and Greybeard. Medical cannabis brands include\u00a0Cannabis\u00a0flos\u00a0Aurora 27\/1,\u00a0MedReleaf,\u00a0CanniMed, Aurora and Whistler Medical Marijuana Co., as well as international brands\u00a0Pedanios,\u00a0IndiMed\u00a0and\u00a0CraftPlant.<\/p>\n<p>Aurora also has a controlling interest in Bevo Farms Ltd.,\u00a0North America&#8217;s\u00a0leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora&#8217;s brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched. Learn more\u00a0at\u00a0<b><a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4576874-1&amp;h=2175791814&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4455047-1%26h%3D613386061%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D4295695-1%2526h%253D3564663324%2526u%253Dhttps%25253A%25252F%25252Fc212.net%25252Fc%25252Flink%25252F%25253Ft%25253D0%252526l%25253Den%252526o%25253D4128153-1%252526h%25253D3697784588%252526u%25253Dhttps%2525253A%2525252F%2525252Fcan01.safelinks.protection.outlook.com%2525252F%2525253Furl%2525253Dhttps%252525253A%252525252F%252525252Fc212.net%252525252Fc%252525252Flink%252525252F%252525253Ft%252525253D0%2525252526l%252525253Den%2525252526o%252525253D4095039-1%2525252526h%252525253D2487444144%2525252526u%252525253Dhttps%25252525253A%25252525252F%25252525252Fwww.auroramj.com%25252525252F%2525252526a%252525253Dwww.auroramj.com%25252526data%2525253D05%252525257C02%252525257CLindsey.Soper%2525252540auroramj.com%252525257C82ce931cfb4f40dbff9408dc399c6b4e%252525257C97ff2d32fc2f4ef0b838e1f27817796c%252525257C0%252525257C0%252525257C638448591171066619%252525257CUnknown%252525257CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%252525253D%252525257C0%252525257C%252525257C%252525257C%25252526sdata%2525253DhWz2RHtP6jEFOCxpxVGoQxyevZVQ0dCNvcGZAl2%252525252F1wo%252525253D%25252526reserved%2525253D0%252526a%25253Dwww.auroramj.com%2526a%253Dwww.auroramj.com%26a%3Dwww.auroramj.com&amp;a=www.auroramj.com\" target=\"_blank\" rel=\"nofollow\">www.auroramj.com<\/a><\/b>\u00a0and follow us on\u00a0<b><a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4576874-1&amp;h=1540449874&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4455047-1%26h%3D2294557072%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D4295695-1%2526h%253D2085879903%2526u%253Dhttps%25253A%25252F%25252Fc212.net%25252Fc%25252Flink%25252F%25253Ft%25253D0%252526l%25253Den%252526o%25253D4128153-1%252526h%25253D2857970268%252526u%25253Dhttps%2525253A%2525252F%2525252Ftwitter.com%2525252FAurora_MMJ%252526a%25253DX%2526a%253DX%26a%3DX&amp;a=X\" target=\"_blank\" rel=\"nofollow\">X<\/a><\/b>\u00a0and\u00a0<b><a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4576874-1&amp;h=704729965&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4455047-1%26h%3D1384185007%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D4295695-1%2526h%253D1548729162%2526u%253Dhttps%25253A%25252F%25252Fc212.net%25252Fc%25252Flink%25252F%25253Ft%25253D0%252526l%25253Den%252526o%25253D4128153-1%252526h%25253D3400495928%252526u%25253Dhttps%2525253A%2525252F%2525252Fwww.linkedin.com%2525252Fcompany%2525252F6440508%2525252Fadmin%2525252Ffeed%2525252Fposts%2525252F%252526a%25253DLinkedIn%2526a%253DLinkedIn%26a%3DLinkedIn&amp;a=LinkedIn\" target=\"_blank\" rel=\"nofollow\">LinkedIn<\/a><\/b>.\u00a0<\/p>\n<p>Aurora&#8217;s common shares trade on the NASDAQ and TSX under the symbol &#8220;ACB&#8221;.\u00a0<\/p>\n<p>\n        <b>Forward Looking Information\u00a0<\/b>\u00a0<\/p>\n<p>This news release includes statements containing certain &#8220;forward-looking information&#8221; within the meaning of applicable securities law (&#8220;<b>forward-looking statements<\/b>&#8220;). Forward-looking statements are frequently characterized by words such as &#8220;plan&#8221;, &#8220;continue&#8221;, &#8220;expect&#8221;, &#8220;project&#8221;, &#8220;intend&#8221;, &#8220;believe&#8221;, &#8220;anticipate&#8221;, &#8220;estimate&#8221;, &#8220;may&#8221;, &#8220;will&#8221;, &#8220;potential&#8221;, &#8220;proposed&#8221; and other similar words, or statements that certain events or conditions &#8220;may&#8221; or &#8220;will&#8221; occur. Forward-looking statements made in this news release include, but are not limited to, statements regarding the expansion of the Company&#8217;s portfolio of high-potency medical cannabis products in <span class=\"xn-location\">Poland<\/span>, the Company&#8217;s continued leadership in international medical cannabis, competitive advantages in scientific expertise and regulatory knowledge, and continued commitment to innovation to support patient access and market growth across Europe.<\/p>\n<p>These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the magnitude and duration of potential new or increased tariffs imposed on goods imported from <span class=\"xn-location\">Canada<\/span> into <span class=\"xn-location\">the United States<\/span>; the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer sales channels, management&#8217;s estimates of consumer demand in <span class=\"xn-location\">Canada<\/span> and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration of acquired business and operations, management&#8217;s estimation that SG&amp;A will grow only in proportion of revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises and other risks, uncertainties and factors set out under the heading &#8220;Risk Factors&#8221; in the Company&#8217;s annual information from dated <span class=\"xn-chron\">June 17<\/span>, 2025\u00a0 (the &#8220;AIF&#8221;) and filed with Canadian securities regulators available on the Company&#8217;s issuer profile on SEDAR+ at <u><a href=\"http:\/\/www.sedarplus.com\" rel=\"nofollow\">www.sedarplus.com<\/a><\/u> and filed with and available on the SEC&#8217;s website at <u><a href=\"http:\/\/www.sec.gov\" rel=\"nofollow\">www.sec.gov<\/a><\/u>. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=TO43694&amp;sd=2025-12-11\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland-302638229.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland-302638229.html<\/a><\/p>\n<p>SOURCE  Aurora Cannabis Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=TO43694&amp;Transmission_Id=202512110700PR_NEWS_USPR_____TO43694&amp;DateId=20251211\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire Latest Innovation\u00a0Brings New\u00a0Proprietary Cultivar\u00a0to Polish Patients\u00a0 NASDAQ\u00a0| TSX: ACB EDMONTON, AB , Dec. 11, 2025 \/PRNewswire\/ &#8211; Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces the launch of Black Jelly, a proprietary cultivar,\u00a0in Poland, expanding\u00a0the\u00a0company&#8217;s\u00a0portfolio\u00a0of high-potency medical cannabis products in one of Europe&#8217;s fastest-growing markets. Grown and manufactured in Aurora&#8217;s Canadian GACP and EU-GMP certified\u00a0facilities, Black Jelly joins\u00a0Farm Gas\u00a0and\u00a0Sourdough\u00a0under the\u00a0Cannabis\u00a0flos\u00a0Aurora brand portfolio. &#8220;Aurora\u00a0is uniquely positioned to bring this novel\u00a0proprietary cultivar to\u00a0the\u00a0Polish market\u00a0thanks to the\u00a0company&#8217;s\u00a0advanced\u00a0genetic breeding program\u00a0and\u00a0unmatched\u00a0global cultivation excellence,&#8221;\u00a0said\u00a0Andreas Dotterweich, Senior VP of Aurora Europe. &#8220;We\u00a0deeply\u00a0understand that prescribers want reliable, high-potency medical cannabis options for their patients, and we&#8217;re proud to offer\u00a0superior products\u00a0that consistently meet prescriber and patient needs.&#8221;\u00a0 Black Jelly will &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Aurora Expands Leading Portfolio of High-Potency Medical Flower Products in Poland&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-918671","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aurora Expands Leading Portfolio of High-Potency Medical Flower Products in Poland - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aurora Expands Leading Portfolio of High-Potency Medical Flower Products in Poland - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire Latest Innovation\u00a0Brings New\u00a0Proprietary Cultivar\u00a0to Polish Patients\u00a0 NASDAQ\u00a0| TSX: ACB EDMONTON, AB , Dec. 11, 2025 \/PRNewswire\/ &#8211; Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces the launch of Black Jelly, a proprietary cultivar,\u00a0in Poland, expanding\u00a0the\u00a0company&#8217;s\u00a0portfolio\u00a0of high-potency medical cannabis products in one of Europe&#8217;s fastest-growing markets. Grown and manufactured in Aurora&#8217;s Canadian GACP and EU-GMP certified\u00a0facilities, Black Jelly joins\u00a0Farm Gas\u00a0and\u00a0Sourdough\u00a0under the\u00a0Cannabis\u00a0flos\u00a0Aurora brand portfolio. &#8220;Aurora\u00a0is uniquely positioned to bring this novel\u00a0proprietary cultivar to\u00a0the\u00a0Polish market\u00a0thanks to the\u00a0company&#8217;s\u00a0advanced\u00a0genetic breeding program\u00a0and\u00a0unmatched\u00a0global cultivation excellence,&#8221;\u00a0said\u00a0Andreas Dotterweich, Senior VP of Aurora Europe. &#8220;We\u00a0deeply\u00a0understand that prescribers want reliable, high-potency medical cannabis options for their patients, and we&#8217;re proud to offer\u00a0superior products\u00a0that consistently meet prescriber and patient needs.&#8221;\u00a0 Black Jelly will &hellip; Continue reading &quot;Aurora Expands Leading Portfolio of High-Potency Medical Flower Products in Poland&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-11T13:23:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2842794\/Aurora_Cannabis_Inc__Aurora_Expands_Leading_Portfolio_of_High_Po.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Aurora Expands Leading Portfolio of High-Potency Medical Flower Products in Poland\",\"datePublished\":\"2025-12-11T13:23:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\\\/\"},\"wordCount\":1007,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2842794\\\/Aurora_Cannabis_Inc__Aurora_Expands_Leading_Portfolio_of_High_Po.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\\\/\",\"name\":\"Aurora Expands Leading Portfolio of High-Potency Medical Flower Products in Poland - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2842794\\\/Aurora_Cannabis_Inc__Aurora_Expands_Leading_Portfolio_of_High_Po.jpg\",\"datePublished\":\"2025-12-11T13:23:46+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2842794\\\/Aurora_Cannabis_Inc__Aurora_Expands_Leading_Portfolio_of_High_Po.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2842794\\\/Aurora_Cannabis_Inc__Aurora_Expands_Leading_Portfolio_of_High_Po.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aurora Expands Leading Portfolio of High-Potency Medical Flower Products in Poland\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aurora Expands Leading Portfolio of High-Potency Medical Flower Products in Poland - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\/","og_locale":"en_US","og_type":"article","og_title":"Aurora Expands Leading Portfolio of High-Potency Medical Flower Products in Poland - Market Newsdesk","og_description":"PR Newswire Latest Innovation\u00a0Brings New\u00a0Proprietary Cultivar\u00a0to Polish Patients\u00a0 NASDAQ\u00a0| TSX: ACB EDMONTON, AB , Dec. 11, 2025 \/PRNewswire\/ &#8211; Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces the launch of Black Jelly, a proprietary cultivar,\u00a0in Poland, expanding\u00a0the\u00a0company&#8217;s\u00a0portfolio\u00a0of high-potency medical cannabis products in one of Europe&#8217;s fastest-growing markets. Grown and manufactured in Aurora&#8217;s Canadian GACP and EU-GMP certified\u00a0facilities, Black Jelly joins\u00a0Farm Gas\u00a0and\u00a0Sourdough\u00a0under the\u00a0Cannabis\u00a0flos\u00a0Aurora brand portfolio. &#8220;Aurora\u00a0is uniquely positioned to bring this novel\u00a0proprietary cultivar to\u00a0the\u00a0Polish market\u00a0thanks to the\u00a0company&#8217;s\u00a0advanced\u00a0genetic breeding program\u00a0and\u00a0unmatched\u00a0global cultivation excellence,&#8221;\u00a0said\u00a0Andreas Dotterweich, Senior VP of Aurora Europe. &#8220;We\u00a0deeply\u00a0understand that prescribers want reliable, high-potency medical cannabis options for their patients, and we&#8217;re proud to offer\u00a0superior products\u00a0that consistently meet prescriber and patient needs.&#8221;\u00a0 Black Jelly will &hellip; Continue reading \"Aurora Expands Leading Portfolio of High-Potency Medical Flower Products in Poland\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\/","og_site_name":"Market Newsdesk","article_published_time":"2025-12-11T13:23:46+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2842794\/Aurora_Cannabis_Inc__Aurora_Expands_Leading_Portfolio_of_High_Po.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Aurora Expands Leading Portfolio of High-Potency Medical Flower Products in Poland","datePublished":"2025-12-11T13:23:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\/"},"wordCount":1007,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2842794\/Aurora_Cannabis_Inc__Aurora_Expands_Leading_Portfolio_of_High_Po.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\/","name":"Aurora Expands Leading Portfolio of High-Potency Medical Flower Products in Poland - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2842794\/Aurora_Cannabis_Inc__Aurora_Expands_Leading_Portfolio_of_High_Po.jpg","datePublished":"2025-12-11T13:23:46+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2842794\/Aurora_Cannabis_Inc__Aurora_Expands_Leading_Portfolio_of_High_Po.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2842794\/Aurora_Cannabis_Inc__Aurora_Expands_Leading_Portfolio_of_High_Po.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aurora-expands-leading-portfolio-of-high-potency-medical-flower-products-in-poland\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Aurora Expands Leading Portfolio of High-Potency Medical Flower Products in Poland"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/918671","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=918671"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/918671\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=918671"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=918671"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=918671"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}